[go: up one dir, main page]

IN2013MU02047A - - Google Patents

Download PDF

Info

Publication number
IN2013MU02047A
IN2013MU02047A IN2047MU2013A IN2013MU02047A IN 2013MU02047 A IN2013MU02047 A IN 2013MU02047A IN 2047MU2013 A IN2047MU2013 A IN 2047MU2013A IN 2013MU02047 A IN2013MU02047 A IN 2013MU02047A
Authority
IN
India
Prior art keywords
mscs
relates
treating
injury
osteoarthritis
Prior art date
Application number
Inventor
Satish Mahadeorao Totey
Manoj Kumar C Reddy
Lyle Carl Fonseca
Shashank Gowda
Aarya HARI
Basavaraj Chougule
Minita Sodhi
Original Assignee
Kasiak Res Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kasiak Res Pvt Ltd filed Critical Kasiak Res Pvt Ltd
Priority to IN2047MU2013 priority Critical patent/IN2013MU02047A/en
Priority to PCT/IN2013/000583 priority patent/WO2014203268A2/en
Publication of IN2013MU02047A publication Critical patent/IN2013MU02047A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to a method for isolation, purification and industrial scale expansion of equine adipose tissue derived mesenchymal stem cells (MSCs). The invention also relates to a method for treating and a therapeutic product for treating tendon injury, ligament injury, osteoarthritis and exercise induced pulmonary hemorrhage comprising MSCs.
IN2047MU2013 2013-06-17 2013-09-26 IN2013MU02047A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IN2047MU2013 IN2013MU02047A (en) 2013-06-17 2013-09-26
PCT/IN2013/000583 WO2014203268A2 (en) 2013-06-17 2013-09-26 Method for isolation, purification and industrial scale expansion of equine adipose tissue derived mensenchymal stem cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2047MU2013 IN2013MU02047A (en) 2013-06-17 2013-09-26

Publications (1)

Publication Number Publication Date
IN2013MU02047A true IN2013MU02047A (en) 2015-06-05

Family

ID=52105423

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2047MU2013 IN2013MU02047A (en) 2013-06-17 2013-09-26

Country Status (2)

Country Link
IN (1) IN2013MU02047A (en)
WO (1) WO2014203268A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007508018A (en) 2003-10-08 2007-04-05 べト−ステム インコーポレイテッド Method for preparing and using a novel stem cell composition, and kit containing the composition
CN107828726A (en) * 2017-12-15 2018-03-23 北京焕生汇生物技术研究院 A kind of method of the fractionation of fatty mescenchymal stem cell from fat
EP3720948A1 (en) 2018-03-12 2020-10-14 Universidade do Porto Compositions for use in the treatment of musculoskeletal conditions and methods for producing the same leveraging the synergistic activity of two different types of mesenchymal stromal/stem cells
AU2023323861A1 (en) * 2022-08-11 2025-02-27 Boehringer Ingelheim Vetmedica Gmbh Mesenchymal stem cells for use in the treatment of insect-bite hypersensitivity in equines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100209399A1 (en) * 2009-02-13 2010-08-19 Celavie Biosciences, Llc Brain-derived stem cells for repair of musculoskeletal system in vertebrate subjects
EP2504426B1 (en) * 2009-11-27 2016-09-28 Stempeutics Research PVT. Ltd. Methods of preparing mesenchymal stem cells, compositions and kit thereof
WO2011101834A1 (en) * 2010-02-22 2011-08-25 Advanced Neuro-Science Allies Private Limited A method for obtaining mesenchymal stem cells, media, methods and composition thereof
US20120149098A1 (en) * 2010-12-10 2012-06-14 Davide VANNONI Extraction of process for mesenchymal stromal stem cells
US20130129688A1 (en) * 2011-11-09 2013-05-23 Allocure, Inc. Assay for the Prediction of Therapeutic Effectiveness or Potency of Mesenchymal Stem Cells, and Methods of Using Same

Also Published As

Publication number Publication date
WO2014203268A3 (en) 2015-03-26
WO2014203268A2 (en) 2014-12-24

Similar Documents

Publication Publication Date Title
IN2013MU02046A (en)
IN2013MU02045A (en)
CO6940433A2 (en) Metalloenzyme inhibitor compounds
MX2016002571A (en) Transduction buffer.
MX2013005549A (en) Heterocycle amines and uses thereof.
MX2015012502A (en) Dna-pk inhibitors.
BR112015006393A2 (en) method for producing a fabric product, fabric product produced by a process, and treatment method
ECSP15043422A (en) A PROCEDURE TO INCREASE THE FORMATION OF PYROGLUTAMIC ACID FROM A PROTEIN
MX375872B (en) PROCEDURE FOR THE PREPARATION OF SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES.
MX390739B (en) COMPOSITION OF COMPRESSED BONE AND METHOD OF USING SAME.
CR20140554A (en) DIMETIL-BENZOIC ACID COMPOUNDS
UY34660A (en) BENZODIOXAN INHIBITORS OF LEUCOTRENE PRODUCTION
UY34725A (en) NEW DERIVATIVES OF TIENOPIRIMIDINE, PROCESSES FOR ITS PREPARATION AND ITS THERAPEUTIC USES.
PH12016501777A1 (en) Novel lactobacillus paracasei strain
CR20140553A (en) PIPERIDINE PHENOXIETIL COMPOUNDS
MX2015003701A (en) Treatment compositions.
MX2016012784A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions.
UY35438A (en) PROCEDURE TO PREPARE INHIBITORS OF GLUCOSILCERAMIDE SINTASA.
BR112018008931A2 (en) "compounds for treating hypoproliferative disorders"
IN2013MU02047A (en)
FI20126067A (en) Method and equipment for treatment of the substance classified as waste, product produced by the method and use of the product
ECSP14032516A (en) N- [4- (QUINOLIN-4-ILOXI) CYCLOHEXIL (METHYL)] (HETERO) ARIL-CARBOXAMIDES AS ANDROGEN RECEPTOR ANTAGONISTS, THEIR PRODUCTION AND USES AS MEDICINAL PRODUCTS
TW201613569A (en) Composition consisting of kukoamine A and/or kukoamine B and method of using thereof
MX2016012758A (en) HYPEROSMOLAR COMPOSITION OF Hyaluronic Acid.
AR091240A1 (en) SCHMALLENBERG VIRUS VACCINE (SBV), PRODUCTION METHODS AND ITS USES